What is it about?
Calcium silicate/CaB6 composites were made by wet precipitation. XRD showed quartz, CaSi2O5, CaB6, and cristobalite after 550 °C heating. Exotherms at 821–950 °C indicated CaB6 decomposition and calciborite formation. Particles were submicron to nano-sized. After 2 weeks in SBF, EDX confirmed calcium phosphate spheres; XRD/FT-IR revealed hydroxyapatite and coesite, indicating biocompatibility.
Featured Image
Why is it important?
Our work is unique for introducing CaB6 normally used in electronics and refractories into a calcium silicate system for bone regeneration, a combination rarely studied in biomaterials. It's timely because bone tissue engineering increasingly needs multifunctional materials that both promote bone growth and offer added therapeutic benefits. Your composite shows bioactivity through hydroxyapatite formation in SBF, and related studies demonstrate drug delivery potential plus improved bone healing in rat models. You're repurposing an overlooked material into a promising bioactive orthopedic platform.
Perspectives
In my view, this study opens a promising but still early path. CaB6 is rare in biomaterials, so the SBF results showing hydroxyapatite growth are encouraging. However, in vitro bioactivity alone doesn't prove true biocompatibility cell studies and in vivo testing are essential next steps. I'd also want to see how the composite degrades over time and whether boron release stays within safe limits. The nano-scale structure is a real strength, but controlling it reproducibly will matter for clinical translation.
Gehan El-Bassyouni
National Research Centre (NRC), Dokki, Cairo, 12622, Egypt
Read the Original
This page is a summary of: Preparation, characterization and biocompatibility of nominal wollastonite/calcium hexaboride composites, Materials Chemistry and Physics, September 2022, Elsevier,
DOI: 10.1016/j.matchemphys.2022.126337.
You can read the full text:
Contributors
The following have contributed to this page
